The return (?) of postmastectomy radiotherapy
A Recht
JCO Dec 1 1995: 2861–2864. [PDF]
Docetaxel: current status and future prospects
E Eisenhauer
JCO Dec 1 1995: 2865–2868. [PDF]
	Adequate locoregional treatment for early breast cancer may prevent secondary dissemination
	R Arriagada, LE Rutqvist, A Mattsson, A Kramar, and S Rotstein
	JCO Dec 1 1995: 2869–2878. [Abstract] [PDF]
	Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer
	PM Ravdin, HA Burris, 3rd, G Cook, P Eisenberg, M Kane, WA Bierman, J Mortimer, E Genevois, and RE Bellet
	JCO Dec 1 1995: 2879–2885. [Abstract] [PDF]
	Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer
	V Valero, FA Holmes, RS Walters, RL Theriault, L Esparza, G Fraschini, GA Fonseca, RE Bellet, AU Buzdar, and GN Hortobagyi
	JCO Dec 1 1995: 2886–2894. [Abstract] [PDF]
	Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy
	AY Bedikian, GR Weiss, SS Legha, HA Burris, 3rd, JR Eckardt, J Jenkins, O Eton, AC Buzaid, L Smetzer, and DD Von Hoff
	JCO Dec 1 1995: 2895–2899. [Abstract] [PDF]
	Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer
	H Gylling, S Pyrhonen, E Mantyla, H Maenpaa, L Kangas, and TA Miettinen
	JCO Dec 1 1995: 2900–2905. [Abstract] [PDF]
	Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?
	CE Leonard, ME Wood, B Zhen, J Rankin, DA Waitz, L Norton, K Howell, and S Sedlacek
	JCO Dec 1 1995: 2906–2915. [Abstract] [PDF]
	High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study
	MA Shipp, D Neuberg, M Janicek, GP Canellos, and LN Shulman
	JCO Dec 1 1995: 2916–2923. [Abstract] [PDF]
	Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study
	K Kelly, JJ Crowley, PA Bunn, Jr, MB Hazuka, K Beasley, C Upchurch, GR Weiss, WJ Hicks, DR Gandara, and S Rivkin
	JCO Dec 1 1995: 2924–2930. [Abstract] [PDF]
	Association of malignant brain tumors and cancers of other sites
	H Ahsan, AI Neugut, and JN Bruce
	JCO Dec 1 1995: 2931–2935. [Abstract] [PDF]
	Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer
	CG Moertel, TR Fleming, JS Macdonald, DG Haller, JA Laurie, CM Tangen, JS Ungerleider, WA Emerson, DC Tormey, and JH Glick
	JCO Dec 1 1995: 2936–2943. [Abstract] [PDF]
	Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy
	R Sridhara, MA Eisenberger, VJ Sinibaldi, LM Reyno, and MJ Egorin
	JCO Dec 1 1995: 2944–2953. [Abstract] [PDF]
	Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation?
	J Boos, S Krumpelmann, P Schulze-Westhoff, T Euting, F Berthold, and H Jurgens
	JCO Dec 1 1995: 2954–2960. [Abstract] [PDF]
	Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study
	P Francis, E Rowinsky, J Schneider, T Hakes, W Hoskins, and M Markman
	JCO Dec 1 1995: 2961–2967. [Abstract] [PDF]
	Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil
	DJ Kerr, JA Ledermann, CS McArdle, J Buckels, J Neoptolemos, M Seymour, J Doughty, J Budden, and I Taylor
	JCO Dec 1 1995: 2968–2972. [Abstract] [PDF]
	Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia
	MR O'Donnell, GD Long, PM Parker, J Niland, A Nademanee, M Amylon, N Chao, RS Negrin, GM Schmidt, and ML Slovak
	JCO Dec 1 1995: 2973–2979. [Abstract] [PDF]
Presidential address. May 22, 1995 Thirty-First Annual Meeting of the American Society of Clinical Oncology
K Antman
JCO Dec 1 1995: 2980–2989. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.